China would make any coronavirus vaccine it developed a “global public good” once it was put into use, President Xi Jinping told the World Health Assembly on Monday.

China has five potential vaccines in clinical trials as countries race to find a way to stop the pathogen that has killed over 315,000 people worldwide.

In his speech, Xi said: “After the research and development of China’s coronavirus vaccine is completed and it is put into use, it will be made a global public good.”

World Health Assembly WHA
The World Health Assembly. Photo: Wikicommons.

This move would be China’s contribution to achieving accessibility and affordability of a vaccine in developing countries as well, Xi said.

More vaccine candidates are in the pipeline and awaiting approval for human trials, said Zeng Yixin, deputy director of the National Health Commission, last week.

Experts say it will take at least 12 to 18 months to develop an effective vaccine, or an even longer period.

Xi also told the assembly’s first-ever virtual gathering that China will provide US$2 billion in global COVID-19 aid over two years.

Support HKFP  |  Policies & Ethics  |  Error/typo?  |  Contact Us  |  Newsletter  | Transparency & Annual Report | Apps

Safeguard press freedom; keep HKFP free for all readers by supporting our team

HK$
HK$

Members of HK$150/month unlock 8 benefits: An HKFP deer keyring or tote; exclusive Tim Hamlett columns; feature previews; merch drops/discounts; "behind the scenes" insights; a chance to join newsroom Q&As, early access to our Annual/Transparency Report & all third-party banner ads disabled.

The Trust Project HKFP
Journalist Trust Initiative HKFP
Society of Publishers in Asia
International Press Institute
Oxfam Living Wage Employer
Google Play hkfp
hkfp app Apple
hkfp payment methods
YouTube video
YouTube video

Agence France-Press (AFP) is "a leading global news agency providing fast, comprehensive and verified coverage of the events shaping our world and of the issues affecting our daily lives." HKFP relies on AFP, and its international bureaus, to cover topics we cannot. Read their Ethics Code here